Apimeds Pharmaceuticals US, Inc. (APUS) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $10.84M | +690.3% |
| 2024 | $1.37M | +251.4% |
| 2023 | $390.2K | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $10.84M | +690.3% |
| 2024 | $1.37M | +251.4% |
| 2023 | $390.2K | — |